MedTwenty

Company Intelligence

Permanent company pages, built from verified records

Financials, executives, products, competitors, funding history, acquisitions and the MedTwenty Company Score. Coverage deepens as verified events accumulate — pages show what is known, not what is assumed.

CompanySectorHeadquartersValuationLast roundMedTwenty Score
AbridgeAmbient AIPittsburgh, United States$5.3bnSeries D, September 2026MedTwenty Score 92
OptumProviders · PayersEden Prairie, United StatesNot separately reportedSubsidiary of UnitedHealth GroupMedTwenty Score 88
TempusDiagnostics · AIChicago, United States$8.1bnIPO, June 2024MedTwenty Score 87
MerckPharmaceuticalsRahway, United StatesNot disclosedListedMedTwenty Score 85
Viz.aiStroke Detection · AISan Francisco, United States$1.8bnSeries D, September 2026MedTwenty Score 84
Foundation MedicineCancer GenomicsCambridge, United StatesNot disclosedWholly owned by RocheMedTwenty Score 81
PaigeDigital PathologyNew York, United States$710mSeries C, September 2026MedTwenty Score 79
Hippocratic AIHealthcare LLMPalo Alto, United States$2.1bnSeries B, September 2026MedTwenty Score 76
PersonalisCancer GenomicsFremont, United States$1.5bn (acquisition)Acquired, September 2026MedTwenty Score 74
Eko HealthCardiac AIOakland, United States$640mSeries C, September 2026MedTwenty Score 72
Spire HealthcarePrivate HospitalsLondon, United KingdomNot disclosedListed (LSE)MedTwenty Score 70
Babylon UKDigital HealthLondon, United KingdomNot disclosedRestructured, 2024MedTwenty Score 54